FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to dermatology and can be applied for eczema treatment. For this purpose additionally to complex drug therapy administered is seramil intramuscularly in dose 0.5 mg every second day. Treatment course consists of 10 days.
EFFECT: method provides effective treatment, absence of side effects, reduction of recurrence number, stable remission, accompanied by normalisation of immune system and reduction of treatment terms.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH LICHEN PLANUS | 2014 |
|
RU2564907C1 |
METHOD OF TREATING CHRONIC DERMATOSES | 2018 |
|
RU2709534C1 |
METHOD OF TREATING PATIENTS WITH LOCALISED SCLERODERMA | 2014 |
|
RU2564905C1 |
METHOD FOR TREATMENT OF PATIENTS WITH ROSACEA | 2022 |
|
RU2787970C1 |
METHOD FOR TREATMENT OF ALLERGODERMIA | 2002 |
|
RU2210374C1 |
METHOD FOR TREATMENT OF PATIENTS WITH LICHEN PLANUS | 2016 |
|
RU2629601C1 |
METHOD OF TREATING ECZEMA | 2014 |
|
RU2576834C2 |
METHOD FOR TREATING MICROBIAL ECZEMA | 2000 |
|
RU2185194C2 |
LIPID COMPLEX FOR TREATMENT OF CHRONIC DERMATOSES | 1998 |
|
RU2159118C2 |
METHOD OF TREATMENT OF NEURODERMITE AND PSORIASIS | 1992 |
|
RU2007179C1 |
Authors
Dates
2011-03-20—Published
2009-10-16—Filed